SE382560B - PROCEDURE FOR THE PREPARATION OF ACETYL SALICYLIC ACID INCLUDING PHARMACEUTICAL ACCEPTABLE SALTS AND COMPLEX THEREOF CONTAINING DELAYED PHARMACEUTICAL COMPOSITIONS - Google Patents

PROCEDURE FOR THE PREPARATION OF ACETYL SALICYLIC ACID INCLUDING PHARMACEUTICAL ACCEPTABLE SALTS AND COMPLEX THEREOF CONTAINING DELAYED PHARMACEUTICAL COMPOSITIONS

Info

Publication number
SE382560B
SE382560B SE7112796A SE1279671A SE382560B SE 382560 B SE382560 B SE 382560B SE 7112796 A SE7112796 A SE 7112796A SE 1279671 A SE1279671 A SE 1279671A SE 382560 B SE382560 B SE 382560B
Authority
SE
Sweden
Prior art keywords
complex
procedure
preparation
acceptable salts
salicylic acid
Prior art date
Application number
SE7112796A
Other languages
Swedish (sv)
Inventor
S Casadio
E Sclavi
R Perego
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of SE382560B publication Critical patent/SE382560B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7112796A 1970-10-09 1971-10-08 PROCEDURE FOR THE PREPARATION OF ACETYL SALICYLIC ACID INCLUDING PHARMACEUTICAL ACCEPTABLE SALTS AND COMPLEX THEREOF CONTAINING DELAYED PHARMACEUTICAL COMPOSITIONS SE382560B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE382560B true SE382560B (en) 1976-02-09

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7112796A SE382560B (en) 1970-10-09 1971-10-08 PROCEDURE FOR THE PREPARATION OF ACETYL SALICYLIC ACID INCLUDING PHARMACEUTICAL ACCEPTABLE SALTS AND COMPLEX THEREOF CONTAINING DELAYED PHARMACEUTICAL COMPOSITIONS

Country Status (8)

Country Link
US (1) US3853988A (en)
CA (1) CA974883A (en)
DE (1) DE2149699A1 (en)
DK (1) DK129434B (en)
ES (1) ES395533A1 (en)
FR (1) FR2110314B1 (en)
GB (1) GB1357737A (en)
SE (1) SE382560B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (en) * 1979-01-23 1980-08-07 Hoechst Ag DEPOT BODY BASED ON SILICONE RUBBER AND METHOD FOR THE PRODUCTION THEREOF
FR2514261B1 (en) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog NOVEL COMPOSITION FOR COATING FOODS AND DRUGS AND GRANULES THUS COATED
DE3508097A1 (en) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt COMBINATION PRODUCT MADE OF XANTHINE DERIVATIVES AND O-ACETYLSALICYL ACID OR THEIR PHARMACOLOGICALLY COMPATIBLE SALTS AND THE USE THEREOF
FR2653338B1 (en) * 1989-10-23 1994-06-10 Dow Corning Sa FORMULATION FOR SUSTAINED RELEASE DRUGS AND THE USE THEREOF.
AU706351B2 (en) * 1994-03-18 1999-06-17 Alfred Schmidt The use of dimeticone as a transport and carrier system and/or drug delivery system
DE4409357C2 (en) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Use of Dimeticon to eradicate Heliobacter pylori
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5855915A (en) 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
BR112014031471B1 (en) * 2012-07-17 2020-12-01 Dow Global Technologies Llc liquid composition, use of liquid composition, solid dispersion, process for producing the solid dispersion and process for coating a dosage form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
DK129434C (en) 1975-03-10
FR2110314B1 (en) 1975-06-06
DE2149699A1 (en) 1972-04-13
GB1357737A (en) 1974-06-26
CA974883A (en) 1975-09-23
US3853988A (en) 1974-12-10
DK129434B (en) 1974-10-14
ES395533A1 (en) 1974-10-16
FR2110314A1 (en) 1972-06-02

Similar Documents

Publication Publication Date Title
SE393800B (en) PROCEDURE FOR THE PREPARATION OF BENZOYLAMINO-ALKYL-PHENOXY-ALKYLCARBONIC ACID DERIVATIVES WITH LIPID-SINGING EFFECT
SE413578B (en) PROCEDURE FOR PREPARATION OF ORAL MEDICINAL PRODUCTS WITH EXTENDED EFFECTS
SE385872B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN STATED P-CARBONYL - PHENOXI - ISO - BUTTERIC ACID ESTERS
SE398229B (en) PROCEDURE FOR THE PREPARATION OF 4-PHENOXI-PHENOXIAL CANCARBONIC ACID DERIVATIVES
SE409460B (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL ACCEPTABLE ACID ADDITIONAL SALTS OF AMINOGLYCOSID ANTIBIOTICS
NO138630C (en) PROCEDURE FOR PREPARATION OF 7BETA-ACYLAMIDO-3-METHYL-CEPH-3-EM-4-CARBOXYLIC ACID ESTERS
SE385885B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-6-ARYLPYRIMIDINE DERIVATIVES
SE382560B (en) PROCEDURE FOR THE PREPARATION OF ACETYL SALICYLIC ACID INCLUDING PHARMACEUTICAL ACCEPTABLE SALTS AND COMPLEX THEREOF CONTAINING DELAYED PHARMACEUTICAL COMPOSITIONS
SE7611316L (en) PROSTANIC ACID DERIVATIVES AND METHODS OF PREPARATION THEREOF
SE385698B (en) PROCEDURE FOR THE PREPARATION OF QUINOLINETIC ACID DERIVATIVES
IL37467A0 (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
IL40457A0 (en) New esters and salts of oburnamine type alkaloids,their preparation and pharmaceutical compositions containing them
SE400551B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-AMINO-5-CARBAMYLBENZOIC ACID DERIVATIVES
SE399708B (en) PROCEDURE FOR THE PREPARATION OF THIOXANTONE-2-CARBOXYLIC ACID DERIVATIVES
SE420919B (en) PROCEDURE FOR THE PREPARATION OF N? 722-DANSYL-L-ARGIN INGREDIENTS AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
SE406195B (en) PROCEDURE FOR THE PREPARATION OF BENZOCYCLOHEPTAISOCHINOLINE DERIVATIVES AND THEIR ACID ADDITIONAL SALTS THEREOF
SE396010B (en) PROCEDURE FOR THE PREPARATION OF ACTIVE SUBSTANCE CONTAINING PREPARATIONS WITH LONG-TERM EFFECT IN THE FORM OF TABLETS, DRAGONS OR CAPSULES
SE393801B (en) PROCEDURE FOR THE PREPARATION OF THICARCARBAMIC ACID DERIVATIVES WITH ANTIFUNGISTATIC MEDICINES
SE402111B (en) ANALOGICAL PROCEDURE FOR PREPARATION OF PREGNANIC ACID DERIVATIVES
SE394434B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN STATED S-TRIAZINE DERIVATIVES AND ITS PHARMACEUTICAL ACCEPTABLE
SE380517B (en) PROCEDURE FOR PREPARATION OF FLUORENE-2-ACTIC ACID DERIVATIVES WITH ANTI-INFLAMMATORY EFFECT
SE401829B (en) PROCEDURE FOR THE PREPARATION OF 5-PHENYL-6,7-BENZOMORPHENE DERIVATIVES AND SALTS THEREOF
IL30307A0 (en) Novel derivatives of acetic acid,their preparation and pharmaceutical compositions containing them
IL37586A (en) Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same
SE388195B (en) PROCEDURE FOR THE PREPARATION OF 2,5-DIHYDROXYBENSENESULPHONIC ACID DERIVATIVES WITH HEMOSTATIC HYPOCOLESTEROLEMIC, HYPOTRIGLYCERIDEMIC AND HYPOLIPEMIC EFFECTS